Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eran Ophir

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|May 9, 2012
The use of donor-derived veto cells in hematopoietic stem cell transplantationEran Ophir, Yair Reisner
International Immunopharmacology|January 20, 2009
Induction of tolerance in organ recipients by hematopoietic stem cell transplantationEran Ophir, Yair Reisner
Biochimica Et Biophysica Acta|August 5, 2015
Personalized approaches to active immunotherapy in cancerEran Ophir, Sara Bobisse, George Coukos, et al.
Blood|January 1, 2010
Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cellsEran Ophir, Yaki Eidelstein, Ran Afik, et al.
The Journal of Biological Chemistry|July 26, 2006
The structural context of disease-causing mutations in gap junctionsSarel J Fleishman, Adi D Sabag, Eran Ophir, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2006
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Oleg Butovsky, Maya Koronyo-Hamaoui, Gilad Kunis, et al.
Best Practice & Research. Clinical Haematology|September 20, 2011
Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: the role of ex-vivo generated donor CD8+ T cells with central memory phenotypeEran Ophir, Yaki Eidelstein, Esti Bachar-Lustig, et al.
Neuron|December 24, 2013
Flow of cortical activity underlying a tactile decision in miceZengcai V Guo, Nuo Li, Daniel Huber, et al.
Cancer Discovery|March 10, 2021
Therapeutic Targeting of Checkpoint Receptors within the DNAM1 AxisZoya Alteber, Maya F Kotturi, Sarah Whelan, et al.
Experimental Hematology|December 18, 2024
The inhibitory receptor PVRIG is dominantly expressed in the bone marrow of patients with multiple myeloma and its blockade enhances T-cell engager's immune activationMasha Frenkel, Zoya Alteber, Ning Xu, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|May 9, 2012
The use of donor-derived veto cells in hematopoietic stem cell transplantationEran Ophir, Yair Reisner
International Immunopharmacology|January 20, 2009
Induction of tolerance in organ recipients by hematopoietic stem cell transplantationEran Ophir, Yair Reisner
Biochimica Et Biophysica Acta|August 5, 2015
Personalized approaches to active immunotherapy in cancerEran Ophir, Sara Bobisse, George Coukos, et al.
Blood|January 1, 2010
Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cellsEran Ophir, Yaki Eidelstein, Ran Afik, et al.
The Journal of Biological Chemistry|July 26, 2006
The structural context of disease-causing mutations in gap junctionsSarel J Fleishman, Adi D Sabag, Eran Ophir, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2006
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Oleg Butovsky, Maya Koronyo-Hamaoui, Gilad Kunis, et al.
Best Practice & Research. Clinical Haematology|September 20, 2011
Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: the role of ex-vivo generated donor CD8+ T cells with central memory phenotypeEran Ophir, Yaki Eidelstein, Esti Bachar-Lustig, et al.
Neuron|December 24, 2013
Flow of cortical activity underlying a tactile decision in miceZengcai V Guo, Nuo Li, Daniel Huber, et al.
Cancer Discovery|March 10, 2021
Therapeutic Targeting of Checkpoint Receptors within the DNAM1 AxisZoya Alteber, Maya F Kotturi, Sarah Whelan, et al.
Experimental Hematology|December 18, 2024
The inhibitory receptor PVRIG is dominantly expressed in the bone marrow of patients with multiple myeloma and its blockade enhances T-cell engager's immune activationMasha Frenkel, Zoya Alteber, Ning Xu, et al.
Pageof 3